Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
BMC Systems Biology|August 16, 2011
A systems biology strategy for predicting similarities and differences of drug effects: evidence for drug-specific modulation of inflammation in atherosclerosisRobert Kleemann, Svetlana Bureeva, Ally Perlina, et al.
Frontiers in Immunology|December 5, 2019
Network-Based Selection of Candidate Markers and Assays to Assess the Impact of Oral Immune Interventions on Gut FunctionsMarjolein Meijerink, Tim J van den Broek, Remon Dulos, et al.
International Journal of Molecular Sciences|December 23, 2018
Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLDEveline Gart, Everton Souto Lima, Frank Schuren, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 19, 2019
Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP MiceMarianne G Pouwer, Elsbet J Pieterman, Shu-Ching Chang, et al.
International Journal of Molecular Sciences|September 8, 2019
Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver SteatosisKanita Salic, Eveline Gart, Florine Seidel, et al.
Biomedicines|June 26, 2025
Improved Translational Relevance of In Vitro Fibrosis Models by Integrating IOX2-Mediated Hypoxia-Mimicking PathwaysManuel A González Hernández, Jennifer Venhorst, Lars Verschuren, et al.
Frontiers in Physiology|December 3, 2021
Mechanism-Based Biomarker Prediction for Low-Grade Inflammation in Liver and Adipose TissueJolanda H M van Bilsen, Willem van den Brink, Anita M van den Hoek, et al.
International Journal of Obesity (2005)|October 11, 2018
Evaluation of chitotriosidase as a biomarker for adipose tissue inflammation in overweight individuals and type 2 diabetic patientsRoel Tans, Janna A van Diepen, Sabina Bijlsma, et al.
Frontiers in Cardiovascular Medicine|June 28, 2018
The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse ModelMarianne G Pouwer, Elsbet J Pieterman, Lars Verschuren, et al.
Frontiers in Endocrinology|April 5, 2021
Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent MedicineAndrea M Mueller, Robert Kleemann, Eveline Gart, et al.
Pageof 9